EWA
AKTS

EverSource Wealth Advisors’s Aktis Oncology AKTS Stock Holding History

EverSource Wealth Advisors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58K Buy
+80
New +$1.64K ﹤0.01% 3619

Other funds holding AKTS

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

EverSource Wealth Advisors's AKTS Position: Q2 2026 in Review

EverSource Wealth Advisors opened a new position in Aktis Oncology (AKTS) in Q2 2026: 80 shares worth $2.58K. The stake represents ﹤0.01% of the portfolio and ranks #3619 among its holdings.

21 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • EverSource Wealth Advisors held 80 shares of Aktis Oncology worth $2.58K as of Q2 2026.
  • Aktis Oncology was a new EverSource Wealth Advisors position in Q2 2026.
  • Aktis Oncology made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3619 holding.
  • 21 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.